Abstract:Gastric ulcer syndrome most often appears in horses as erosions and ulcers of the squamous gastric mucosa. It is believed that gastric ulcers of various etiologies are determined by the amount of gastric acidity regulated by the secretion of hydrochloric acid (HCL). At the same time, the squamous portion of the stomach is the most sensitive to HCL. When ulcers appear, medical treatment is effective. This medicine includes gastric acid suppressor drugs like “Omeprazole”. The mechanism of action whose final stage is to inhibit HCL secretion at the cellular level. Today the importance of antisecretory therapy is well known in treating gastroesophageal reflux and peptic ulcer diseases in humans. However, the acid-suppressive effect of “Omeprazole” in horses with gastric ulcers requires further research. This study aimed to determine the therapeutic efficacy and acid-suppressive effect of the proton pump inhibitor “Omeprazole” in doses of 2 mg/kg and 4 mg/kg. For this purpose, n = 14 horses were selected for the research with the equine gastric squamous disease of various degrees. Gastric squamous portion were observed by gastroscopy procedure and presented with mild lesions in selected horses. Diagnosis of lesions and determination of therapeutic efficacy of the drug was carried out based on gastroscopy results. The drug was administered per os for 21 days. The intragastric pH value determined the acid-supressive effect of the drug. Collection of the samples was conducted on the 1st, 5th, 10th, and 21st day of the medical therapy. Before “Omeprazole” was administrated, the basal pH level was 3.45 ± 0.23. After the first dose of the “Omeprazole” was administered at 4 mg/kg the average pH value was 5.25 ± 0.34. At the same time, the “Omeprazole” at a dose of 2 mg/kg provides intragastric pH 4.41 ± 0.33. The therapeutic efficacy of “Omeprazole” is closely related to the intragastric pH of the horses. The “Omeprazole” at a dose of 4mg/kg is highly effective in treating squamous lesions grade 2, 3. However, the duration of therapy for 21 days may not be sufficient to achieve complete healing of the affected tissues. Administration of the “Omeprazole” at a dose of 2 mg/kg is effective in treating small or multifocal lesions and hyperemia of the squamous mucosa.

Efficacy of injectable and oral paste formulations of ivermectin against gastrointestinal parasites in ponies.

Anthelmintic treatment in horses : the extra-label use of products and the danger of under-dosing

An Inactivated Bacterium (paraprobiotic) Expressing Bacillus Thuringiensis Cry5B As a Therapeutic for Ascaris and Parascaris Spp. Infections in Large Animals.

Evaluation of plant commercial feed additives for equine cyathostomin control

Gut Microbial Signatures Associated with Moxidectin Treatment Efficacy of Haemonchus Contortus in Infected Goats.

A New Paraprobiotic-Based Treatment for Control of Haemonchus Contortus in Sheep.

An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes

EFFICACY OF IN-FEED FORMULATION IVERMECTIN AGAINST PSOROPTES SP. IN BIGHORN SHEEP

Phytochemicals in Gastrointestinal Nematode Control: Pharmacokinetic–Pharmacodynamic Evaluation of the Ivermectin plus Carvone Combination

Efficacy of eprinomectin 5 mg/mL topical solution administered pour on at 1 mg per kg body weight against Oestrus ovis myiasis in sheep and goats

Efficacy of sainfoin (Onobrychis viciifolia) pellets against multi resistant Haemonchus contortus and interaction with oral ivermectin: Implications for on-farm control

Ponazuril: Clinical efficacy, ultrastructure, and histopathology studies of in vivo anticoccidial action against Eimeria tenella

Doxycycline as an inhibitor of p-glycoprotein in the alpaca for the purpose of maintaining avermectins in the CNS during treatment for parelaphostrongylosis

Therapeutic efficacy of “Omeprazole” in horses with equine gastric ulcer syndrome

A study investigating the treatment of equine squamous gastric disease with long‐acting injectable or oral omeprazole

Diet modulates strongyle infection and microbiota in the large intestine of horses

Use of Complementary Natural Feed for Gastrointestinal Nematodes Control in Sheep: Effectiveness and Benefits for Animals

Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use

Evaluation of the treatment of equine glandular gastric disease with either long‐acting‐injectable or oral omeprazole

Veterinary oral anthelmintic pastes homogeneous.

A fecal egg count reduction test in grazing beef steers using topical pioneer and generic eprinomectin and fenbendazole oral suspension